USPTO serial 76248470
CELESTAR LEXICO-SCIENCES
Reviewed by CopyMark Law Group
Reg. 2907497Status 710
- Filing date
- Status date
- Registration date
- Dec 7, 2004
- Examiner
- CARRUTHERS, SUE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CELESTAR LEXICO-SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Celestar Lexico-Sciences, Inc.
Chiba-shi, Chiba, JP
Celestar Lexico-Sciences, Inc.
Chiba-shi, Chiba, JP
Celestar Lexico-Sciences, Inc.
Chiba-shi, Chiba, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kaushal R. Odedra
Ray Thomas, Jr. Wenderoth, Lind & Ponack, L.L.P.1030 15th Street N.W.Suite 400 EastWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer programs for use in analyzing and visualizing nucleic acid, protein, and phage information and expression; for use in database management, integration and manipulation; for use in characterization of nucleic acid and protein information; for use in analyzing chemical structure and activity information; for use in acquisition and interrogation of clinical, pathological, diagnostic, genetic, genomic and biochemical data; for use in clinical trial design and management; for use in text and pattern recognition; for storage, retrieval and analysis of life sciences literature; for use in managing robot function; for use in processing toxicological and pharmacological information; for laboratory instrument control; for use in control of sample input to mass spectrometers; for use in spectral analysis; prerecorded CD-ROMs featuring databases containing life sciences information; pre-configured microprocessors for analysis and storage of life sciences information; computer programs for use in the management, storage, retrieval, and analysis for data in the discovery and development of diagnostic, prognostic, and therapeutic medical products; for use in identifying and characterizing proteins; for use in controlling mass spectrometers; for use in spectral analysis; for use in controlling affinity capture optical biosensors; for use in analyzing and characterizing plasmon resonance; for use in controlling liquid chromatography instruments; for use in analyzing chromatograms; for use in controlling microfluidics; for use in controlling single-dimension and multi-dimensional electrophoresis and visualizing and analyzing electrophoretic results; for use in protein analysis and spectral processing; for use in analyzing, managing, and visualizing nucleic acid and amino acid sequences | SECTION 8 - CANCELLED | — |
| 042 | Medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomic, diagnostic, clinical trial design, and biotechnology field; computer services, namely, providing databases featuring life sciences information via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology; computer consulting services, namely, providing databases featuring life sciences information to others via global, national, and local computer networks in the fields of pharmacogenomics, diagnostics, clinical trial design and biotechnology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celestar Lexico-Sciences, Inc.
- Other trademarks owned by Celestar Lexico-Sciences, Inc.
- Other trademarks owned by Celestar Lexico-Sciences, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named CELESTAR LEXICO-SCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 13, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 7, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 14, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 25, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| May 11, 2004 | PAPER RECEIVED | — | |
| Apr 13, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 23, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 2, 2004 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Mar 2, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 2, 2004 | PAPER RECEIVED | — | |
| Sep 2, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Feb 24, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jan 24, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2003 | PAPER RECEIVED | — | |
| Oct 31, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Apr 5, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 8, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2001 | DOCK | ASSIGNED TO EXAMINER | — |